Literature DB >> 1376489

Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines.

D Kvale1, P Krajci, P Brandtzaeg.   

Abstract

T cells and other leucocytes regularly occur within and subjacent to the gut epithelium. Recent data suggest that intestinal epithelial cells may exert accessory immunological functions. Although interactions between leucocytes and accessory cells usually require expression of adhesion molecules, intestinal epithelium has generally been considered negative for intercellular adhesion molecule-1 (ICAM-1) by immunohistochemical techniques. We therefore studied the expression of ICAM-1 and lymphocyte function-associated antigen-3 (LFA-3) by two colonic epithelial cell lines and found that both adhesion molecules were constitutively present at low levels. ICAM-1 protein expression could be enhanced within 4 h by cytokines, particularly after co-incubation with interferon-gamma (IFN) and tumour necrosis factor-alpha (TNF), interleukin-1 beta (IL-1), or IL-6. IFN also resulted in accumulation of ICAM-1 mRNA. Conversely, the LFA-3 expression was virtually unaffected by cytokine stimulation. These data imply that intestinal epithelial cells under certain conditions may bear adhesion molecules required for cooperation with juxtaposed leucocytes in situ, and that the expression of some of these molecules is modulated by cytokines from activated mucosal leucocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376489     DOI: 10.1111/j.1365-3083.1992.tb02973.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  33 in total

1.  Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease.

Authors:  B Vainer; O H Nielsen
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Immunohistochemical analysis of intercellular adhesion molecule-1 expression in human gastric adenoma and adenocarcinoma.

Authors:  R Nasu; M Mizuno; T Kiso; K Shimo; T Uesu; J Nasu; J Tomoda; H Okada; T Tsuji
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

3.  Expression of ICAM-1 on intact cartilage and isolated chondrocytes.

Authors:  J Bujia; U Behrends; N Rotter; P Pitzke; E Wilmes; C Hammer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-02       Impact factor: 2.416

4.  What is the role of human intestinal intraepithelial lymphocytes?

Authors:  L K Trejdosiewicz
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Peripheral blood lymphocyte beta 2 integrin and ICAM expression in inflammatory bowel disease.

Authors:  C N Bernstein; M Sargent; P Rawsthorne; E Rector
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

Review 6.  The intestinal epithelial cell: immunological aspects.

Authors:  A D Christ; R S Blumberg
Journal:  Springer Semin Immunopathol       Date:  1997

7.  Time-course of adhesion molecule expression in rectal mucosa of gluten-sensitive subjects after gluten challenge.

Authors:  A Ensari; A Ager; M N Marsh; S Morgan; K J Moriarty
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.

Authors:  D S McLeod; D J Lefer; C Merges; G A Lutty
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

9.  Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon.

Authors:  S Bloom; D Simmons; D P Jewell
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

10.  Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras.

Authors:  T Gedde-Dahl; E Nilsen; E Thorsby; G Gaudernack
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.